RNA toxicity is a component of ataxin-3 degeneration in Drosophila

被引:243
|
作者
Li, Ling-Bo [1 ]
Yu, Zhenming [1 ,2 ]
Teng, Xiuyin [1 ,2 ]
Bonini, Nancy M. [1 ,2 ]
机构
[1] Univ Penn, Dept Biol, Philadelphia, PA 19104 USA
[2] Univ Penn, Howard Hughes Med Inst, Philadelphia, PA 19104 USA
关键词
D O I
10.1038/nature06909
中图分类号
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号
07 ; 0710 ; 09 ;
摘要
Polyglutamine (polyQ) diseases are a class of dominantly inherited neurodegenerative disorders caused by the expansion of a CAG repeat encoding glutamine within the coding region of the respective genes(1). The molecular and cellular pathways underlying polyQ-induced neurodegeneration are the focus of much research, and it is widely considered that toxic activities of the protein, resulting from the abnormally long polyQ tract, cause pathogenesis(2,3). Here we provide evidence for a pathogenic role of the CAG repeat RNA in polyQ toxicity using Drosophila. In a Drosophila screen for modifiers of polyQ degeneration induced by the spinocerebellar ataxia type 3 (SCA3) protein ataxin-3, we isolated an upregulation allele of muscleblind (mbl), a gene implicated in the RNA toxicity of CUG expansion diseases(4-6). Further analysis indicated that there may be a toxic role of the RNA in polyQ-induced degeneration. We tested the role of the RNA by altering the CAG repeat sequence to an interrupted CAACAG repeat within the polyQ-encoding region; this dramatically mitigated toxicity. In addition, expression of an untranslated CAG repeat of pathogenic length conferred neuronal degeneration. These studies reveal a role for the RNA in polyQ toxicity, highlighting common components in RNA-based and polyQ-protein-based trinucleotide repeat expansion diseases.
引用
收藏
页码:1107 / U9
页数:6
相关论文
共 50 条
  • [21] Ataxin-3 is subject to autolytic cleavage
    Mauri, Pier Luigi
    Riva, Matteo
    Ambu, Daniela
    De Palma, Antonella
    Secundo, Francesco
    Benazzi, Louise
    Valtorta, Marco
    Tortora, Paolo
    Fusi, Paola
    FEBS JOURNAL, 2006, 273 (18) : 4277 - 4286
  • [22] Functional analysis of modifiers of the pathogenic poly-Q protein ataxin-3 in Drosophila
    Bilen, Julide
    Bonini, Nancy
    JOURNAL OF NEUROGENETICS, 2006, 20 (3-4) : 88 - 89
  • [23] Elucidation of ataxin-3 and ataxin-7 function by integrative bioinformatics
    Scheel, H
    Tomiuk, S
    Hofmann, K
    HUMAN MOLECULAR GENETICS, 2003, 12 (21) : 2845 - 2852
  • [24] Heterogeneous intracellular localization and expression of ataxin-3
    Trottier, Y
    Cancel, G
    An-Gourfinkel, I
    Lutz, Y
    Weber, C
    Brice, A
    Hirsch, E
    Mandel, JL
    NEUROBIOLOGY OF DISEASE, 1998, 5 (05) : 335 - 347
  • [25] Physiological and pathophysiological characteristics of ataxin-3 isoforms
    Weishaeupl, Daniel
    Schneider, Juliane
    Pinheiro, Barbara Peixoto
    Ruess, Corinna
    Dold, Sandra Maria
    von Zweydorf, Felix
    Gloeckner, Christian Johannes
    Schmidt, Jana
    Riess, Olaf
    Schmidt, Thorsten
    JOURNAL OF BIOLOGICAL CHEMISTRY, 2019, 294 (02) : 644 - 661
  • [26] Study of subcellular localization and proteolysis of ataxin-3
    Pozzi, Chiara
    Valtorta, Marco
    Tedeschi, Gabriiella
    Galbusera, Elena
    Pastori, Valentina
    Bigi, Alessandra
    Nonnis, Simona
    Grassi, Eleonora
    Fusi, Paola
    NEUROBIOLOGY OF DISEASE, 2008, 30 (02) : 190 - 200
  • [27] Temperature profoundly affects ataxin-3 fibrillogenesis
    Apicella, Alessandra
    Natalello, Antonino
    Frana, Anna Maria
    Baserga, Andrea
    Casari, Carlo Spartaco
    Bottani, Carlo Enrico
    Doglia, Silvia Maria
    Tortora, Paolo
    Regonesi, Maria Elena
    BIOCHIMIE, 2012, 94 (04) : 1026 - 1031
  • [28] Proteolytic cleavage of polyglutamine-expanded ataxin-3 is critical for aggregation and sequestration of non-expanded ataxin-3
    Haacke, A
    Broadley, SA
    Boteva, R
    Tzvetkov, N
    Hartl, FU
    Breuer, P
    HUMAN MOLECULAR GENETICS, 2006, 15 (04) : 555 - 568
  • [29] Gene expression profiling in ataxin-3 expressing cell lines reveals distinct effects of normal and mutant ataxin-3
    Evert, BO
    Vogt, IR
    Vieira-Saecker, AM
    Ozimek, L
    de Vos, RAI
    Brunt, ERP
    Klockgether, T
    Wüllner, U
    JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY, 2003, 62 (10): : 1006 - 1018
  • [30] Conformational Behavior and Aggregation of Ataxin-3 in SDS
    Saunders, Helen M.
    Hughes, Victoria A.
    Cappai, Roberto
    Bottomley, Stephen P.
    PLOS ONE, 2013, 8 (07):